CaDAnCe-101
Phase 1/2 Recruiting
614 enrolled
MAHOGANY
Phase 3 Recruiting
780 enrolled
A Study of Surovatamig (AZD0486) Plus Rituximab in Previously Untreated Follicular Lymphoma Patients
Phase 3 Recruiting
1,018 enrolled
A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
Phase 1 Recruiting
572 enrolled
A Study of Mevrometostat for Treatment of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma
Phase 1 Recruiting
453 enrolled
CAN3001
Phase 3 Recruiting
700 enrolled
OLYMPIA-1
Phase 3 Recruiting
822 enrolled
A Phase I Study of HY-2003 in the Subjects With Excessive Submental Fat Accumulation
Phase 1 Recruiting
30 enrolled
OLYMPIA-5
Phase 3 Recruiting
470 enrolled
NETTER-3
Phase 3 Recruiting
240 enrolled
SIGMA
Phase 3 Recruiting
365 enrolled
A Study to Assess Safety and Efficacy of CHO-H01 as a Single Agent/Combined With Lenalidomide in Subjects With Refractory or Relapsed Non-Hodgkin's Lymphoma
Phase 1/2 Recruiting
37 enrolled
EPCOREâ„¢FL-2
Phase 3 Recruiting
1,095 enrolled
Aquarius
Recruiting
550 enrolled
Dose Escalation and Dose Expansion Study of MDX2003 in Patients With Different Types of Lymphoma
Phase 1/2 Recruiting
180 enrolled
SYMPHONY-1
Phase 3 Recruiting
612 enrolled
NEO100 and High-Grade Meningioma
Phase 2 Recruiting
30 enrolled
A Study of Debio 0123 in Combination With Temozolomide in Adult Participants With Recurrent or Progressive Glioblastoma and of Debio 0123 in Combination With Temozolomide and Radiotherapy in Adult Participants With Newly Diagnosed Glioblastoma
Phase 1/2 Recruiting
116 enrolled
SOUNDTRACK-B
Phase 2 Recruiting
240 enrolled
Study of LYL314 in Aggressive Large B-Cell Lymphoma
Phase 1/2 Recruiting
270 enrolled
Long-term Follow up Local Registry Study of Kymriah in South Korea
Recruiting
500 enrolled
EpcoReal
Recruiting
700 enrolled
Study of Oral Administration of LP-168 in Patients With Relapsed or Refractory B-cell Malignancies.
Phase 1 Recruiting
60 enrolled
Study of SGR-1505 in Mature B-Cell Neoplasms
Phase 1 Recruiting
98 enrolled
Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)
Phase 1/2 Recruiting
32 enrolled
TITANium
Phase 1/2 Recruiting
174 enrolled
This is a Phase 1 Study to Evaluate the Safety of LTZ-301 in Patients With Non-Hodgkin Lymphoma
Phase 1 Recruiting
42 enrolled
AQUAx2
Phase 2 Recruiting
276 enrolled
Evaluate the Safety and Clinical Activity of HH2853
Phase 1/2 Recruiting
254 enrolled
SIDNEY
Phase 1/2 Recruiting
80 enrolled
RUBIN
Recruiting
2,950 enrolled
The Suitability of Tience® for Treating Acne Scars
Phase NA Recruiting
20 enrolled
Study to Evaluate Adverse Events, Change in Disease Activity, and How Oral ABBV-101 Moves Through the Body in Adult Participants With B-Cell Malignancies
Phase 1 Recruiting
340 enrolled
Study to Evaluate Adverse Events, Change in Disease Activity, and How Intravenously Infused ABBV-291 Moves Through the Body in Adult Participants With Non-Hodgkin's Lymphoma
Phase 1 Recruiting
165 enrolled
A Study to Assess the Adverse Events, Change in Disease Activity, and How Intravenously Infused ABBV-319 Moves Through the Bodies of Adult Participants With Relapsed or Refractory (R/R) Diffuse Large B-cell Lymphoma (DLBCL), Follicular Lymphoma (FL), or Chronic Lymphocytic Leukemia (CLL)
Phase 1 Recruiting
154 enrolled
STARI
Phase NA Recruiting
30 enrolled
ON-5001
Phase 1 Recruiting
168 enrolled
SynKIR-310 for Relapsed/Refractory B-NHL
Phase 1 Recruiting
18 enrolled
APOLLO-EU
Phase NA Recruiting
400 enrolled
AS-1763 in Patients With Previously Treated CLL/SLL or Non-Hodgkin Lymphoma
Phase 1 Recruiting
120 enrolled
A Study to Compare the Efficacy and Safety of Golcadomide in Combination With Rituximab (Golca + R) vs Investigator's Choice in Participants With Relapsed/Refractory Follicular Lymphoma Who Have Received at Least 1 Prior Line of Systemic Therapy (GOLSEEK-4)
Phase 3 Recruiting
400 enrolled
Deucravacitinib for Patients With Moderate/Severe Psoriasis: A Real-Life Experience in Italy
Recruiting
200 enrolled
A Safety and Efficacy Study Evaluating CTX112 in Subjects With Relapsed or Refractory B-Cell Malignancies
Phase 1/2 Recruiting
120 enrolled
OPAL
Phase 1/2 Recruiting
144 enrolled
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Recruiting
50,000 enrolled
A Study of AC676 for the Treatment of Relapsed/Refractory B-Cell Malignancies
Phase 1 Recruiting
60 enrolled
IKS03 in Patients With Advanced B Cell Non-Hodgkin Lymphomas
Phase 1 Recruiting
140 enrolled
Autologous Adipose-Derived Mesenchymal Stem Cells for Chronic Traumatic Brain Injury
Phase 2 Recruiting
51 enrolled
MAPLE-UK
Recruiting
250 enrolled
ARIADNE
Recruiting
705 enrolled